Bivalent oral cholera vaccine in participants aged 1 year and older in the Dominican Republic: A phase III, single-arm, safety and immunogenicity trial

about

Bivalent oral cholera vaccine in participants aged 1 year and older in the Dominican Republic: A phase III, single-arm, safety and immunogenicity trial

Item

http://www.wikidata.org/entity/Q57940864

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в червні 2018

@uk

name

Bivalent oral cholera vaccine ...... afety and immunogenicity trial

@en

Bivalent oral cholera vaccine ...... afety and immunogenicity trial

@nl

type

Item

label

Bivalent oral cholera vaccine ...... afety and immunogenicity trial

@en

Bivalent oral cholera vaccine ...... afety and immunogenicity trial

@nl

prefLabel

Bivalent oral cholera vaccine ...... afety and immunogenicity trial

@en

Bivalent oral cholera vaccine ...... afety and immunogenicity trial

@nl

P1476

Bivalent oral cholera vaccine ...... afety and immunogenicity trial

@en

P2093

Anvar Rasuli

http://www.w3.org/2001/XMLSchema#string

Badri Narayan Patnaik

http://www.w3.org/2001/XMLSchema#string

Eric Desauziers

http://www.w3.org/2001/XMLSchema#string

Jesús Feris-Iglesias

http://www.w3.org/2001/XMLSchema#string

Lina Cordero De Los Santos

http://www.w3.org/2001/XMLSchema#string

Naveena Aloysia D'Cor

http://www.w3.org/2001/XMLSchema#string

Venkata Jayanth Midde

http://www.w3.org/2001/XMLSchema#string

Yaël Thollot

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India

Two-sided confidence intervals for the single proportion: comparison of seven methods

Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in Haiti.

Vibrio cholerae O139 conjugate vaccines: synthesis and immunogenicity of V. cholerae O139 capsular polysaccharide conjugates with recombinant diphtheria toxin mutant in mice.

Flexibility of oral cholera vaccine dosing-a randomized controlled trial measuring immune responses following alternative vaccination schedules in a cholera hyper-endemic zone.

Vibriocidal antibody responses in North American volunteers exposed to wild-type or vaccine Vibrio cholerae O139: specificity and relevance to immunity.

An Open Label Non-inferiority Trial Assessing Vibriocidal Response of a Killed Bivalent Oral Cholera Vaccine Regimen following a Five Year Interval in Kolkata, India.

Updated global burden of cholera in endemic countries.

A Randomized, Placebo-Controlled Trial Evaluating Safety and Immunogenicity of the Killed, Bivalent, Whole-Cell Oral Cholera Vaccine in Ethiopia

Effectiveness of Oral Cholera Vaccine in Haiti: 37-Month Follow-Up.

P304

1403-1411

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21645515.2018.1430540

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29470934

http://www.w3.org/2001/XMLSchema#string

P921

immunology

Binghsiqrueg

Farmakologi

P932

6037475

http://www.w3.org/2001/XMLSchema#string